Results 131 to 140 of about 15,145 (185)

Genetic Architecture of Synaptic Failure in Dementia with Lewy Bodies: From α-Synuclein Proteoforms to GBA1-Mediated Plasticity Deficits. [PDF]

Genes (Basel)
Bougea A.
europepmc   +1 more source

Hemiplegic migraine: genetics and pathophysiology. [PDF]

J Clin Invest
Pietrobon D.
europepmc   +1 more source

NMDA Receptor: An Old but Refreshed Target for Neurodegeneration. [PDF]

NeuroSci
Marques JM, Rodrigues RJ.
europepmc   +1 more source

Predominant NR1-positive puncta with limited PSD95 colocalization and close GluA2-EAAT2 apposition in the preBötzinger complex. [PDF]

Histochem Cell Biol
Olmos-Pastoresa CA, Vázquez-Mendoza E, Vázquez-Martínez O, López-Meraz ML, Beltran-Parrazal L, Morgado-Valle C.   +5 more
europepmc   +1 more source

The multimodal transcriptional response of denervated skeletal muscle involves regulation of <i>Gramd1</i> genes impacting muscle size. [PDF]

Proc Natl Acad Sci U S A
Calvo C, Swoboda CO, Montecino-Morales F, Nagar S, Petrany MJ, Sun C, Bindu Durumutla H, Quattrocelli M, Millay DP.   +8 more
europepmc   +1 more source

Ceftriaxone alleviates mitochondrial damage through the inhibition of extrasynaptic NMDA receptor-mediated changes in intracellular calcium levels to improve cognitive deficits in APP/PS1 mice. [PDF]

Alzheimers Res Ther
Liu LR, Li L, Lu LL, Fan SJ, Liu LZ, He RB, Li H, Xian XH, Li WB.   +8 more
europepmc   +1 more source

Ethanol disrupts cerebellar synaptic modulation by enhancing EAAT4-mediated glutamate uptake. [PDF]

Commun Biol
Satake S.
europepmc   +1 more source

Antibody-Mediated Mechanisms in Autoimmune Neurological Disorders. [PDF]

Eur J Neurosci
Maudes E, Marmolejo L, Serafim AB, Spatola M, Compte A, Dalmau J.   +5 more
europepmc   +1 more source

Antiseizure Medications in Development: Novel Mechanisms, Precision Therapy, and the Move Towards Disease Modification. [PDF]

Curr Issues Mol Biol
Martins WA.
europepmc   +1 more source